Loading…
CIK 0000882095 • 6 13F filings • May 13, 2025 – Aug 3, 2026
Import this data to Google Sheets with:
=jivedata("gilead-sciences-inc","13f")Uses this filer's slug. Install the Jive Data add-on first; the second argument is "13f".
Past 5 quarters
| % of Portfolio | |||||
|---|---|---|---|---|---|
| ARCELLX INC | COMMON STOCK | $438.2M | 22.6%Prev: 30.8% | 6,720,803 SH | Decreased |
| ARCUS BIOSCIENCES INC | COM | $748.9M | 38.7%Prev: 23.9% | 31,424,760 SH | Increased |
| ASSEMBLY BIOSCIENCES INC | COM NEW | $153.2M | 7.9%Prev: 6.4% | 4,505,391 SH | Increased |
| GALAPAGOS NV | SPON ADR | $550.6M | 28.4%Prev: 32.3% | 16,707,477 SH | Decreased |
| KYVERNA THERAPEUTICS INC | COM | $38.8M | 2.0%Prev: 1.4% | 4,126,119 SH | Increased |
| XILIO THERAPEUTICS INC | COM | $5.8M | 0.3%Prev: 0.4% | 9,105,451 SH | Decreased |
| 13F-HR |
| 0001123292-26-001034 |
| $1.65B |
| View |
| Aug 14, 2025 | Q2 2025 | 13F-HR | 0001123292-25-000364 | $1.28B | View |
| May 8, 2026 | Q1 2026 | 13F-HR | 0001123292-26-000642 | $2.12B | View |
| May 13, 2025 | Q1 2025 | 13F-HR | 0001123292-25-000217 | $1.18B | View |